Opening book details…
About this Medicine article
17β hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma by Marta Szajnik; Miroslaw J. Szczepanski; Esther Elishaev; Carmen Visus; Diana Lenzner; Maciej Zabel; Marta Glura; Albert B. DeLeo; Theresa L. Whiteside is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Marta Szajnik; Miroslaw J. Szczepanski; Esther Elishaev; Carmen Visus; Diana Lenzner; Maciej Zabel; Marta Glura; Albert B. DeLeo; Theresa L. Whiteside
- Publisher
- Elsevier Science; Elsevier ; Elsevier Inc.; Elsevier BV (ISSN 0090-8258)
- Published
- 2012
- Language
- EN
- Field
- Medicine (Health Sciences)